SCHEMBL29909202

SCHEMBL29909202

CN(c1cccc(-c2ccc(NC(=O)OC(C)(C)C)cc2)c1)c1nc2nncn2c2cc(Cl)ccc12

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
MAP4K4 O95819 1/20 0.37
CYP17A1 P05093 4/20 0.36
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
TP53 P04637 1/20 0.36
PARP1 P09874 1/20 0.35
PLAU P00749 1/20 0.35
JAK2 O60674 1/20 0.35
CNR1 P21554 2/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
F10 P00742 2/20 0.33
CDK1 P06493 1/20 0.33
BRD4 O60885 1/20 0.33
UTS2R Q9UKP6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601388 1.00 ATM (0.40) ATMMAP4K4CYP17A1EGFRSRC
SCHEMBL23576714 0.90 NPC1 (0.38) MAP4K4TP53PLAUCNR1FNTA
SCHEMBL29909287 0.90 NPC1 (0.38) MAP4K4TP53PLAUCNR1FNTA
SCHEMBL29909468 0.89 TP53 (0.47) ATMTP53PLAUCNR1FNTA
SCHEMBL23576656 0.89 TP53 (0.39) TP53PLAUCNR1FNTAFNTB
SCHEMBL23576968 0.89 TP53 (0.47) ATMTP53PLAUCNR1FNTA
SCHEMBL29909868 0.85 P2RY14 (0.38) BRD4
SCHEMBL24721497 0.85 P2RY14 (0.38) BRD4
SCHEMBL23577248 0.85 FNTA (0.38) MAP4K4TP53FNTAFNTBF10
SCHEMBL29909890 0.85 FNTA (0.38) MAP4K4TP53FNTAFNTBF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361236-A9 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2025-11-27 US disclosed
US-20240400568-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2024-12-05 US disclosed
EP-4445902-A2 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2024-10-16 EP disclosed
EP-4081305-B1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES INC (JP) 2024-09-18 EP disclosed
US-20240182476-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2024-06-06 US disclosed
US-11845723-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2023-12-19 US disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400568-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK ATM 839/4885MAP4K4 236/4885CYP17A1 4211/4885
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK ATM 839/4885MAP4K4 236/4885CYP17A1 4211/4885
US-11845723-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK ATM 839/4885MAP4K4 236/4885CYP17A1 4211/4885
US-20240182476-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK ATM 839/4885MAP4K4 236/4885CYP17A1 4211/4885
US-20250361236-A9 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK ATM 839/4885MAP4K4 236/4885CYP17A1 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.